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Abstract New virtual cocrystal screening was proposed
taking advantage of the similarities between cocrystal-
lization landscapes of different compounds. Assuming that
cocrystallization propensities can be modeled by misci-
bility affinities of liquid components under supercooled
conditions, the quantitative rules of likeness were formu-
lated and validated for 45 aromatic and heteroaromatic
amides interacting with a variety of coformers. The most
important finding comes from the observed linear trends
between the values of mixing enthalpies of amides with
respect to a reference molecule. Particularly isonicoti-
namide was found as a very convenient comparative sys-
tem since it constitutes 97 binary cocrystals. Many
experimentally observed cocrystals were used for sup-
porting the analogy hypothesis, which states that a properly
selected reference molecule, for which cocrystals were
experimentally documented, can provide practical infor-
mation about cocrystallization propensities of another
compound provided that two criterions are met, namely
sufficiently high similarities and high enough affinities.
Hence, it is not necessary to perform experimental
cocrystallization of every pair of coformers since misci-
bility in the solid state of one compound can be transferred
to another one at least in the case of aromatic or hetero-
aromatic amides.
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Introduction
Cocrystals are important products of materials science, and
many branches of industry take advantage [1] of the pos-
sibility of tuning properties of solids [2]. This covers,
among other domains, the pharmaceutical [3, 4], agro-
chemical [5, 6] or high-energy industries [6–8]. Not all
multicomponent solids are classified as cocrystals [9] since
at least two criterions must be met [9–13]. First of all, after
cocrystallization, the molded homogeneous phase should
comprise stoichiometric proportions of the components.
Besides, all coformers should be solids under ambient
conditions. The possibility of alteration of the physico-
chemical properties after successful cocrystallization is
especially welcomed in the case of active pharmaceutical
ingredients (API). There are many examples of significant
improvements of API behaviors both in vivo and in vitro
[14, 15] due to enhancement of pharmacokinetic properties
as solubility [4, 16, 17] and bioavailability [18–20]. Also
many other physicochemical properties can be modulated
by cocrystallization including stability [21–24], hygro-
scopicity [25] and prolonged shelf life [26]. Among many
drugs, aromatic amides acting either as APIs or as excip-
ients attract nowadays substantial attention [27–35]. These
compounds are known for their important roles in medical
applications. For example, vitamin B3 or PP are synonyms
for nicotinamide, which is an important compound
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functioning as a component of the coenzyme NAD [36].
Pyrazinamide with its bacteriostatic and bacteriocidal
activities, acting as an efficient antitubercular agent [37],
was also recognized as an important medication. Also
salicylamide and ethenzamide are known as analgesic and
antipyretic drugs [38]. They are used as non-prescription
painkillers belonging to nonsteroidal anti-inflammatory
agents with medicinal uses similar to those of aspirin.
Temozolomide, known under different brand names as
Temodar, Temodal or Temcad, is an orally administered
alkylating agent used in chemotherapy for treatment of
some types of brain cancer and a first-line treatment for
glioblastoma multiforme [39, 40].
Majority of aromatic or heteroaromatic amides are
poorly soluble in water, and cocrystallization with more
soluble formers might be one of the remedies for this
limitation [4]. Although many pharmaceutical cocrystals
containing amides have been studied [27–35], the data
deposited in the Cambridge Structural Database (CSD) [41]
are rather variable in the sense that many coformers were
used for synthesis of diverse cocrystals. For example
cocrystals of fumaric acid with benzamide, isonicotinamide
or nicotinamide are known under refcodes YOPBUB,
LUNNOX and EDAPOQ, respectively, but there is no
information about solids of these coformers with temo-
zolomide. There are information about 4-hydroxybenzoic
acid and 4-nitrobenzoic acid cocrystallization with isoni-
cotinamide, but cocrystal of nicotinamide is known only
with the former compound. There are many such ‘‘gaps,’’
which can be highlighted by retrieving of corresponding
data from the latest edition of the CSD. Of course, lack of
the structure in the CSD does not necessarily indicate that a
specific system has not been studied. There are also
cocrystal screening studies that do not report structures but
provide information about positive or negative cases.
However, experimental verification of all possible combi-
nation of pairs of potential conformers is impractical. That
is why, theoretical cocrystals screening might offer valu-
able guiding clues for cocrystal landscape exploration.
Many theoretical approaches were developed as suit-
able for this purpose, but among them those taking
advantage of relatively inexpensive scans of potential
cocrystallization propensities seem to be worth consider-
ing. For example, characteristics of the electrostatic
potential surface of the interacting molecules can be used
for identification of the most likely contacts [42]. A virtual
cocrystal screening method [43] was successfully validated
against experimental cocrystals. Besides, the mixing
enthalpy of supercooled liquid coformers with a given
stoichiometry can be used for screening of cocrystallization
potential [44–46]. Besides, the supramolecular phenomena
expressed in terms of homo- or heterosynthons proved to
be valuable guidance for practical applications [47–49].
Alternatively the semiquantitative models for predicting
cocrystallization probability were also formulated [50, 51]
in terms of statistical analysis of molecular descriptors
distributions and chemometric analysis.
The aim of this paper is to explore the idea of the
applicability of similarities between cocrystallization
landscapes of different compounds assuming that propen-
sities of cocrystallization can be modeled by miscibility
affinities of components in liquids under supercooled
conditions. As a consequence, a significant extension of the
list of intermolecular complexes in the solid state is
expected, based on existing knowledge of experimentally
verified cases. Also systems that do not cocrystallize can be
potentially identified. This kind of virtual screening relying
on cocrystallization properties of one compound can
potentially offer predictions of cocrystals for other similar
systems. Identification of such cases and formulation of the
suitable rules is the main goal of this paper.
Computation method
Training sets of cocrystals and coformers
The CSD [41] (release 2016) was searched for binary
systems comprising aromatic or heteroaromatic amides.
The list of conformers was built based on composition of
the cocrystals understood accordingly to the most common
definition [9–13]. Hence, systems comprising components
in liquid state under ambient conditions were excluded
from the analysis, as well as ions, polymers, solvates (in-
cluding hydrates) and clathrates. Among all 8543 systems
embracing two distinct chemical units in the entry, there
were found 45 amides involved in 356 cocrystals with 211
distinct coformers. These compounds were used for defi-
nition of the first set of coformers. Additionally, the second
set was also considered by including compounds appearing
on the EAFUS (everything added to the food in US) or
GRAS (generally recognized as safe) lists. This second set
of coformers comprising 677 neutral and solid species
under ambient conditions might be of practical importance
since there are many amides which take part in medical
formulations, as it was already mentioned. Chemical names
of all considered here aromatic and heteroaromatic amides
involved in binary cocrystals were collected in Table 1.
Mixing enthalpy estimation
The cocrystals screening was performed according to
methodology relying on thermodynamic computations of
coformers mixing in the liquid state under supercooled
conditions. This approach was successfully applied to a
variety of systems including cocrystals [44–46]. It assumes
1404 Struct Chem (2016) 27:1403–1412
123
that the miscibility of supercooled liquids is also associated
with miscibility in the solid state. To quantify the affinity
of coformers, the excess thermodynamic functions were
computed for a mixture composed of two components with
given stoichiometric proportions. Particularly, the mixing
enthalpy can be defined as follows:
DHmix12 ¼ H12  x1H11 þ x2H22
  ð1Þ
where subscripts denote solutes, superscripts represent
solvent types and x stands for molar fraction of a given
component. The enthalpy of cocrystal formation, H12, can
be estimated based on the computations in binary liquid as
follows:
H12 ¼ x1H112 þ x2H212 ð2Þ
The excess enthalpy accounts for all energetic contribu-
tions including hydrogen bonding and van der Waals
interactions of all energetically favorable coformers of
each component. The computations were done using
COSMOtherm software [52] at semiempirical level pro-
vided by BP_SVP_AM1_C30_1501.ctd parameter file.
This semiempirical approach is fairly reliable offering
balance between costs of computation and accuracy of
thermodynamic characteristics. The number of structure
considered here prevents from using more sophisticated
levels of computations, especially that it is vital to include
several thermodynamically favorable coformers of each
compound for adequate sampling of the intermolecular
interactions in the modeled liquids. Geometries of all
amides and coformers were optimized using MOPAC2012
[53] both in the gas phase and in condensed phase modeled
with an aid of the conductor like screening model for real
solvents (COSMO-RS) [54, 55] approach. All systems
were mixed with unimolar proportions. It is worth men-
tioning that the highest probability of cocrystallization is
assumed for cases with negative enough Hmix values [45,
52]. Here this threshold was set to -1.30 kcal/mol.
Results and discussion
The cocrystallization propensities of aromatic and
heteroaromatic amides are quite well recognized, which are
documented by numerous records deposited in the CSD.
Table 1 List of aromatic and heteroaromatic amides involved in binary cocrystals
No. Chemical name No. Chemical name
1 Isonicotinamide [97] 24 N,N0-ethane-1,2-diyldinicotinamide [3]
2 Nicotinamide [68] 25 N,N0-octane-1,8-diyldinicotinamide [3]
3 Pyrazinamide [23] 26 4-(1H-pyrazol-1-ylmethyl)benzamide [3]
4 Temozolomide [18] 27 2-Methoxybenzamide [2]
5 Benzamide [17] 28 3-Aminobenzamide [2]
6 Picolinamide [15] 29 4-Methylbenzamide [2]
7 4-Hydroxybenzamide [14] 30 N-(4-fluorophenyl)benzamide [2]
8 2-Ethoxybenzamide [12] 31 N-methylbenzamide [2]
9 4-Bromobenzamide [10] 32 N,N0-butane-1,4-diyldiisonicotinamide [2]
10 4-Nitrobenzamide [9] 33 N-(4-methylphenyl)nicotinamide [2]
11 N,N0-hexane-1,6-diyldinicotinamide [8] 34 2-Methylbenzamide [1]
12 N-(pyridin-2-yl)isonicotinamide [7] 35 2-Chlorobenzamide [1]




15 2-Hydroxybenzamide [5] 38 4-Aminobenzamide [1]
16 N-(6-benzamidohexyl)benzamide [5] 39 N-sec-butylbenzamide [1]
17 4-Chlorobenzamide [5] 40 4-(1H-pyrazol-1-yl)benzamide [1]
18 3,5-Dinitrobenzamide [4] 41 N-(1-(1-naphthyl)ethyl)-3,5-dinitrobenzamide [1]
19 5-Chloro-n-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide [4] 42 N,N-dimethyl-3,5-dinitrobenzamide [1]
20 N,N0-octane-1,8-diyldiisonicotinamide [4] 43 N-(thiazolin-2-yl)-3-(N,N-dimethylamino)benzamide
[1]
21 N,N0-butane-1,4-diyldinicotinamide [4] 44 3-((Benzimidazol-1-yl)methyl)benzamide [1]
22 4-Iodobenzamide [3] 45 3-((2-Methylbenzimidazol-1-yl)methyl)benzamide [1]
23 Pentafluorobenzamide [3]
In brackets, the number of records available in CSD is provided
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However, there are no studies that systematically charac-
terize the whole group of these compounds against a par-
ticular set of coformers. This paper intends to fill this gap
by a methodical and extended comparison of cocrystal-
lization landscapes for inferring practical rules enabling
screening by analogy. In the first part of the paper, such
criterions were formulated and validated. Then, conse-
quences of the observed patterns let for a significant
extension of the list of probable cocrystals formed by
studied class of compounds by enumerating several
examples not verified experimentally but very plausible.
Similarities of mixing properties under supercooled
conditions
It is quite expected that structural similarities of any two
compounds have also consequences on some kind of sim-
ilarities in their intermolecular interactions. This includes
the potential of intermolecular complexes formation, which
is the necessary condition for cocrystallization. One can,
however, raise the question about the quantification of the
similarities between distinct molecules. Since mixing
enthalpy is often used as a first sign of potential stability of
molecular complexes [45, 52], its value seems to be a quite
natural index of similarity of compounds affinities in the
context of homogeneity of condensed phases. For verifi-
cation of this hypothesis, series of pairs involving amides
and other coformers were considered, for which Hmix val-
ues were computed and used as a quantitative measure of
likenesses between different compounds. The main idea
behind such computations is the hope of finding a repre-
sentative accounting for the properties of another com-
pound. Interestingly, this seems to be feasible which can be
directly inferred from the linear trends presented in Fig. 1.
For clarity only the most frequently occurring amides were
used on this graphical presentation. Indeed, the selected
seven amides are involved in 258 of 356 cocrystals found
in the CSD. In the legend of Fig. 1, there are provided
correlations between Hmix distributions of each of the
selected amides with respect to isonicotinamide, which was
set as the referential molecule. Choosing this particular
compound for linear trends identification is justified by the
fact that it is the most frequently occurring cocrystal former
among all the considered aromatic or heteroaromatic
amides. In Fig. 1, there are presented distributions of
excess enthalpies for pairs resulting from all combinations
of amides and coformers belonging to the first set. This of
course includes many systems not necessarily studied
experimentally. In fact, this figure offers quite extended
screening of cocrystallization propensities of studied
amides with all potential coformers belonging to the first
set. The Hmix values characterizing existing cocrystals were
marked with red color. These points represent such pairs
for which experimental data are available for both isoni-
cotinamide and given amide, which is not so common.
The existence of highly linear relationships identified in
Fig. 1 suggests that intermolecular interactions of one
amide with the considered set of coformers can be the
source of information about affinities of another one
toward the same set of probing molecules. Slopes of these
trends can be used for general quantification of components
affinities. For example, the inclination of regression line
shown by temozolomide is equal to 1.21, while for ben-
zamide is much lower and equals 0.84. This suggests that
intermolecular interactions of the former compound with
considered set of coformers are stronger compared to
isonicotinamide and for benzamide the opposite conclusion
is valid. This implies that if isonicotinamide can cocrys-
tallize with given coformer, then it seems to be very
plausible that also temozolomide will have the same abil-
ity. However, inferring by analogy about the possibility of
benzamide cocrystallization based on similarity to isoni-
cotinamide is not so straightforward. Since lower values of
excess enthalpy for systems comprising benzamide are
expected, the values of Hmix should be checked against the
threshold one. In general, in such situations application of
screening by analogy should be done in a reversed manner
and inferring about cocrystallization of isonicotinamide
based on trends of benzamide seems to be more reasonable.
Additionally, it is worth to emphasize some quite
interesting properties of 4-hydroxybenzamide observed in
Fig. 1, for which two distinct patterns are clearly visible.
Separation of these cases leads to the conclusion that one
set is characterized by a very steep slope, with
Fig. 1 Correlation of excess enthalpy distributions of (2) nicoti-
namide, (3) pyrazinamide, (4) temozolomide, (5) benzamide, (6)
picolinamide, (7) 4-hydroxybenzamide and (8) 2-ethoxybenzamide as
a function of Hmix of (1) isonicotinamide. Marked points (in red)
characterize real cocrystals found in the CSD. Brackets in the legend
contain the values of Spearman’s ranks (r) quantifying correlations
between distributions (Color figure online)
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corresponding value exceeding 1.8, while the other trend is
much less inclined with corresponding slope value close to
0.5. This can be explained by the differences in nature of
two substituents constituting 4-hydroxybenzamide. The
interactions of the hydroxyl group can be associated with
higher values of the slope, which suggests that these kinds
of interactions favor interaction between coformers much
stronger than the amide group. Furthermore, the substituent
effect of hydroxyl group on amide interactions can also be
observed. Comparison of Hmix distribution of 4-hydroxy-
benzamide with unsubstituted benzamide leads to the
conclusion that a significant reduction in the affinity of the
amide group of the former compound can be associated
with the presence of an OH substituent. These incongruent
trends characterizing 4-hydroxybenzamide is the reason of
excluding this compound from the procedure of screening
by analogy.
Alternatively, the analysis of affinities similarities
between considered amides interacting with the same set of
coformers can be completed by inspection of distributions
of Hmix values. In Fig. 2, there are provided plots of
smoothed histograms clearly demonstrating that for many
amides one can expect very similar cocrystallization
propensities. All distributions except the ones characteriz-
ing 4-hydroxybenzamide seriously overlap in the whole
presented range including the most important region of
Hmix\-1.30 kcal/mol. Since histograms presented in
Fig. 2 clearly document that the analyzed distributions
failed in fulfilling the requirement of normality, the quan-
tification of regression lines shown in Fig. 1 requires the
utilization of nonparametric correlation coefficient. Hence,
Spearman’s rank (r) was used as a measure of correlations
instead of Pearson’s correlation coefficient (R2) as more
adequate here, since this statistical measure of correlation
relies on the ranking of values rather than means or stan-
dard deviations. These two ways of analysis of Hmix dis-
tributions provided in Figs. 1 and 2 consentaneously
confirm that there are serious similarities in the affinities of
several amides interacting with a common set of coformers.
Based on this observation, the main claim of this work can
be drawn. It states that due to the observed similarities the
transferability of cocrystallization propensities between
different compounds can be expected. The proper selection
of reference compound, as isonicotinamide here, can help
in rationalizing the choice of coformers for experimental
cocrystals screening. Particularly, in the cases of high
enough affinities between coformers, the cocrystallization
of one amide with given coformer can be the sign of similar
properties of the another one.
Taking into account this message, the comprehensive
selection of binary systems was prepared and part of it is
presented in Table 2. A much more extended list can be
found in supplementary materials in Table S1. These
tables compile several examples of known cocrystals
augmented with systems marked as potentially positive in
the case of fulfilling the requirements of high probability of
cocrystallization (Hmix\-1.30 kcal/mol). For example,
succinic acid cocrystallizes with all seven amides included
in Table 1 and this is nicely supported by the predicted
Hmix values since all of them are within the range of high
cocrystallization probability. Fumaric acid was success-
fully cocrystallized with six of the considered amides, but
not with temozolomide. Quite high affinity between these
two compounds, suggested by Hmix values, makes it very
plausible that these two coformers will also form molecular
complex in the solid state. This suggestion is additionally
supported by higher than one value of the slope of linear
regression line presented in Fig. 1. This directly supports
rationality of screening by analogy hypothesis. One can
find much more similar cases. Indeed, isonicotinamide can
cocrystallize with several carboxylic acids, but molecular
complexes of temozolomide with these coformers were not
reported in CSD. This observation resulting from the
highlighted high similarities between two mentioned
amides can be used as a suggestion for experimental vali-
dation of the proposed hypothesis. The inspection of
Table 2 and S1 can lead to many more such suggestions.
For example, according to proposed rule, 4-nitrobenzoic
acid should cocrystallize with nicotinamide, 2-ethoxyben-
zamide and temozolomide. In general, the selection of
isonicotinamide as reference molecule, and transferring its
cocrystallization abilities is practical for those amides for
which slopes of linear trends observed in Fig. 1 are higher
than unity. Based on proposed hypothesis, one can also find
other referential molecules. For example, vanillic acid
Fig. 2 Smoothed histograms documenting the distributions of mixing
enthalpies of (1) isonicotinamide, (2) nicotinamide, (3) pyrazinamide,
(4) temozolomide, (5) benzamide, (6) picolinamide and (7) 4-hy-
droxybenzamide with every compound belonging to the first set of
211 coformers
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cocrystallizes with pyrazinamide, but analogous cocrystal
of isonicotinamide was not reported in CSD. Also the
existence of homogenous solids of 3,5-dinitrobenzoic acid
with all amides except from picolinamide can be inferred
based on their similarities with respect to benzamide. All
corresponding Hmix values are within acceptable range.
However, fair caution should be stated based on the
collection presented in Table 3. It accumulates some
exemplary cases, for which the value of Hmix used for
cocrystal screening can be misguiding. For example, there
were reported cocrystals of temozolomide with some of
considered here amides despite the fact that according to
uncritical inference based on excess heat values such bin-
ary systems should rather exhibit immiscibility in the solid
state. Occurrence of such false negative cases is an inherent
problem of application of Hmix to highly similar compo-
nents. Anyway, the excess function cannot be used for
single component systems, for which by definition
Hmix = 0. Thus, the affinities of two compounds can be so
similar that inferring based on excess function must fail.
Table 2 Shortened version of the list of cocrystals formed by (1) isonicotinamide, (2) nicotinamide, (3) pyrazinamide, (4) temozolomide, (5)
benzamide, (6) picolinamide and (8) 2-ethoxybenzamide
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The CSD code is followed by cocrystal stoichiometry. In parenthesis, values of computed Hmix expressed in kcal/mol are provided. The extended
version is provided in Table S1 of ESI
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Probably some false positive examples might also be
found. Despite these limitations, the proposed approach
can be used for augmenting the virtual cocrystal screening
by taking advantage of analogy. The generality of this rule
can be easily confirmed or falsified by performing series of
experimental screenings, which will be the subject of
forthcoming projects.
Validation of similarities criterion based
on extended coformers list
The first set comprised compounds that have already been
used for cocrystallization with aromatic or heteroaromatic
amides. It would be also interesting to check whether
similar correspondence in mixing abilities between amides
and isonicotinamide is also observed for other types of
coformers. For this purpose, the second set was constructed
including compounds found on the EAFUS and GRAS lists
and a similar analysis was performed as for the first set of
coformers. Interestingly, high linear trends were again
observed also for coformers included in the second set. For
keeping consistency with the data provided in Fig. 1, the
obtained results were compacted to relationships between
computed values of Spearman’s ranks and slopes of
regression lines of Hmix distributions of a given amide with
respect to isonicotinamide. The data presented in Fig. 3
suggest that for both sets of coformers high linear corre-
lations can be found between affinities of isonicotinamide
and many amides. Although there are some exceptions, the
obtained distributions can be characterized by r[ 0.9 for
Table 3 List of some falsely predicted cocrystals based on similarities of Hmix values






















































































Notation is analogous to the one used in Table 2
Struct Chem (2016) 27:1403–1412 1409
123
the majority of considered amides. Thus, high values of
Spearman’s ranks suggesting high linearity can be found
for different sets of coformers and are not just an artifact of
selecting a single series of probing molecules.
The abscissa of Fig. 3 provides characteristics of the
relative affinities of amides toward coformers with respect
to isonicotinamide. As it was mentioned above, the pro-
posed rule of cocrystal screening based on analogy requires
finding a reference molecule for which cocrystals are
known. However, such inferring will have a chance of
success if it is applied to compounds of higher affinities
than the reference molecule that is with higher values of
slopes of regression line. It is possible to find many of such
cases for both sets of coformers. It is worth mentioning that
no restriction was imposed on the data during computation
of both the values of slopes and Spearman’s ranks. Thus,
from one side the plots provided in Fig. 3 offer guidance
for rational selection of the most promising candidates for
reference molecules. On the other hand, it informs the
restrictions of applicability of screening by analogy
approach. The value of slopes of three selected amides is
included in Fig. 3. Thus, selection of benzamide as a ref-
erential molecule for cocrystals screening of other two
amides is justified, but predications in the opposite direc-
tion can lead to misclassification.
Conclusions
The idea of a likeness of different compounds in agreement
with chemical intuition is extended here on the cocrystal-
lization propensities. Particularly, the similarity of liquids
miscibility under supercooled conditions was proposed as a
measure of correspondence between cocrystallization
landscapes of different cocrystal formers. Presented data
provided quite comprehensive screening of cocrystals of
aromatic or hetero-aromatic amides with a variety of
conformers. It has been demonstrated that many of distri-
butions exhibit highly similar patterns in the whole range
of excess enthalpy, which was nicely confirmed by
experimentally observed cocrystals. This suggests that
affinities of one component toward a given set of coformers
can inform about affinities of another chemical species
interacting with the same set of probing molecules. Due to
analogies in the intermolecular interactions in liquids such
similarities can be extended also on cocrystallization
abilities. This is the sense of the hypothesis proposed here,
which states that a properly selected reference molecule,
for which cocrystals were experimentally documented, can
provide practical information about cocrystallization
propensities of another compound provided that two cri-
terions are met. First condition requires high similarities,
which can be expressed in terms of correlations between
excess heat distributions obtained based on the common set
of conformers. Second criterion requires that estimated
Hmix value is within accepted range of high probability
cocrystallization. Despite the fact that there were identified
some systems misclassified as false negatives, many posi-
tive examples were enumerated. The main conclusion
drawn from presented analysis is that it is not necessary to
perform experimental cocrystallization of every pair of
coformers since miscibility in the solid state of one com-
pound can be transferred to another one at least in the case
of aromatic or hetero-aromatic amides. However, general-
ity of conclusion is worth further exploration both theo-
retical and experimental.
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